ArticleBMC psychiatry2025
Sarcopenia and dynapenia are associated with depression rather than anxiety in Chinese hemodialysis patients.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAffective disorders contribute to poorer outcomes in hemodialysis patients. We aimed to investigate the association of depression and anxiety with sarcopenia and dynapenia among patients receiving maintenance hemodialysis.
methodsA total of 1074 patients (676 men, mean aged 61.3 ± 12.6 years) undergoing hemodialysis from 7 facilities in Shanghai of China from 2020 to 2023. Depression was evaluated by the Patient Health Questionnaire-9 (PHQ-9) and anxiety was assessed by the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7). The cut-off values of muscle mass and muscle function to define sarcopenia, dynapenia, and presarcopenia were according to the consensus by the Asia Working Group of Sarcopenia in 2019.
resultsAmong 1074 participants, 160 (14.9%) had depression, 85(7.9%) had anxiety. Patients were divided into four groups: sarcopenia (n = 211), dynapenia(n = 267), presarcopenia(n = 100), and the robust (n = 496) group. The proportion of depression in the group sarcopenia, dynapenia, presarcopenia and robust were 19.4%, 22.8%, 14.0%, and 8.9% (sarcopenia vs. robust P < 0.001; dynapenia vs. robust P < 0.001; overall p value < 0.001). The proportion of anxiety in the four group were 10.4%, 10.5%, 6.0%, and 5.8%, respectively (overall p value > 0.05). Multivariate analysis revealed that sarcopenia, dynapenia, Malnutrition Inflammation Score (MIS), Charlson Comorbidity Index (CCI) and Fractional clearance index for urea (Kt/V) were significant factors linked to the presence of depression.
conclusionOur findings suggest that sarcopenia and dynapenia are associated with depression rather than anxiety in hemodialysis patients. Interventions or programs aiming to alleviate sarcopenia or dynapenia can be effective strategies to prevent depression in the hemodialysis population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.